Medicare Procedure and Patient Information
2014 Medicare Procedure Volume
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 19 |
|---|
(No ratings)
Dr. Scott S. Zamvil, MD, Neurology is a null in San Francisco, CA specializing in psychiatry & neurology, general practice and neurology (brain & spinal cord disease). He graduated from Stanford University School of Medicine in 1988 and has 37 years of experience. Dr. Scott S. Zamvil, MD, Neurology is affiliated with UCSF Health, UCSF Medical Group, Hill Physicians and Multiple Sclerosis and Neuroinflammation Center.
Hill Physicians
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 19 |
|---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 22 |
|---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 33 |
|---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 20 |
|---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 26 |
|---|
Information about Medicare patients treated by Dr. Scott S. Zamvil, MD, Neurology.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 14 |
The most common conditions of Medicare patients that Dr. Scott S. Zamvil, MD, Neurology treated during 2019 were high cholesterol.
| Hypertension | 0 |
|---|---|
| High Cholesterol | 43 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 46 |
|---|
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 65 |
|---|
Information about Medicare patients treated by Dr. Scott S. Zamvil, MD, Neurology.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 12 |
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 68 |
|---|
Information about Medicare patients treated by Dr. Scott S. Zamvil, MD, Neurology.
| From 65 to 74 | 13 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Scott S. Zamvil, MD, Neurology treated during 2022 were high cholesterol.
| Hypertension | 0 |
|---|---|
| High Cholesterol | 42 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 57 |
|---|
Information about Medicare patients treated by Dr. Scott S. Zamvil, MD, Neurology.
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 15 |
The most common conditions of Medicare patients that Dr. Scott S. Zamvil, MD, Neurology treated during 2023 were high cholesterol.
| Hypertension | 0 |
|---|---|
| High Cholesterol | 48 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Volume of procedures performed by Dr. Scott S. Zamvil, MD, Neurology for Medicare patients.
| doctor visit | 39 |
|---|
Information about Medicare patients treated by Dr. Scott S. Zamvil, MD, Neurology.
| 75 to 84 | 0 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 4 |
| 65 to 74 | 1 |
The highest averages of the most common conditions of Medicare patients that Dr. Scott S. Zamvil, MD, Neurology treated were high cholesterol.
| Hypertension | 0 |
|---|---|
| High Cholesterol | 14 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoporosis | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Atrial Fibrillation | 0 |
| Cancer | 0 |
| Dementia | 0 |
Dr. Scott S. Zamvil, MD, Neurology graduated from Stanford University School of Medicine in 1988. He completed residency at Allegheny General Hospital. He is certified by the American Board of Psychiatry and Neurology, Neurology and has a state license in California.
Medical School: Stanford University School of Medicine (1988)
Residency: Allegheny General Hospital
Board Certification: American Board of Psychiatry and Neurology, Neurology (1999)
Licensed In: California
Dr. Scott S. Zamvil, MD, Neurology is associated with these hospitals and organizations:
Dr. Scott S. Zamvil, MD, Neurology appears to accept the following insurance providers: Cigna, Aetna, Blue Shield of California, Anthem, UnitedHealthcare, Health Net, Chinese Community Health Plan, Central Health Plan and Canopy Health.
According to our sources, Dr. Scott S. Zamvil, MD, Neurology accepts the following insurance providers:
Dr. Scott S. Zamvil, MD, Neurology does not have any reviews yet, be the first to leave a review of Dr. Scott S. Zamvil, MD, Neurology here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Scott S. Zamvil, MD, Neurology. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Teva Pharmaceuticals USA, Inc. |
$447,441
COPAXONE $418,645 |
LAQUINIMOD $13,911 |
68546-0142-5 $3,500 |
AZILECT $1,112 |
AJOVY $9 |
Other $10,264 |
|---|---|---|---|---|---|---|
| GENZYME CORPORATION |
$308,882
AUBAGIO $144,685 |
LEMTRADA $60,405 |
ALEMTUZUMAB $22,153 |
NO PRODUCT DISCUSSED $9,564 |
KEVZARA $2,759 |
Other $69,315 |
| Biogen, Inc. |
$155,333
PLEGRIDY $36,191 |
TECFIDERA $26,544 |
TYSABRI $16,232 |
Vumerity $9,988 |
$66,378 |
|
| Biogen Idec Inc. |
$110,363
TECFIDERA $64,585 |
AVONEX $28,208 |
PLEGRIDY $17,497 |
TYSABRI $42 |
$30 |
|
| Horizon Therapeutics plc |
$77,755
UPLIZNA $77,755 |
|||||
| Other |
$228,365
SOLIRIS $29,983 |
Non-Covered Product $20,481 |
BAF312A $16,766 |
NonCovered Product $13,260 |
MAYZENT $11,045 |
Other $136,831 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $507,343 |
|---|---|
| Consulting Fee | $308,878 |
| Honoraria | $238,380 |
| Travel and Lodging | $237,702 |
| Food and Beverage | $35,490 |
| Other | $346 |
Dr. Scott S. Zamvil, MD, Neurology has received 6 research payments totaling $319,945.
Dr. Scott Zamvil's areas of specialization are general practice and neurology (brain & spinal cord disease); he sees patients in San Francisco, CA. Areas of particular interest for Dr. Zamvil include multiple sclerosis (MS). He seems to honor several insurance carriers, including Blue Shield, Health Net, and Anthem. Before performing his residency at Allegheny General Hospital and Brigham and Women's Hospital, Dr. Zamvil attended Stanford University School of Medicine. His professional affiliations include UCSF Medical Group and Hill Physicians. According to Hill Physicians, new patients are welcome to contact Dr. Zamvil's office in San Francisco, CA.